China National Medicines Corporation Ltd. China National Medicines Corporation Ltd.

China National Medicines Corporation Ltd.

600511

Rang in Aktien #4775
China National Medicines Corporation Ltd., in conjunction with its various... China National Medicines Corporation Ltd., in conjunction with its various operating entities, is a prominent player in the distribution of pharmaceutical goods across China. The enterprise's scope extends to the production and commercialization of innovative as well as pre-existing drug formulations. Additionally, it markets both traditional Chinese patent remedies and modern Western medications, alongside a range of medical apparatus. Complementing these activities, the firm delivers warehousing solutions and acts as an agent for import and export transactions. Its diverse clientele encompasses hospitals, retail pharmacies, and other healthcare organizations. Established in 1999, the company maintains its principal office in Beijing, China.
Aktienkurs
$4.14
Zuletzt synchronisiert: 2026-10-21
Marktkapitalisierung
$3.12B
Veränderung (1 Tag)
6.06%
Veränderung (1 Jahr)
-1.39%
Land
CN
Handel China National Medicines Corporation Ltd. (600511)

Kategorie

Healthcare
Kursverlauf für China National Medicines Corporation Ltd. (600511)
Höchster Schlusskurs: $3.93 am 2026-10-01

Niedrigster Schlusskurs: $0.31 am 2002-11-01
Kursverlauf der Aktie von China National Medicines Corporation Ltd. von 2002 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -1.27%
2025 -13.13%
2024 17.23%
2023 -0.55%
2022 -15.12%
2021 -36.77%
2020 107.87%
2019 3.39%
2018 -12.12%
2017 -10.09%
2016 -17.32%
2015 8.27%
2014 76.11%
2013 30.66%
2012 2.44%
2011 -44.30%
2010 2.93%
2009 81.45%
2008 -3.96%
2007 242.53%
2006 279.57%
2005 -7.33%
2004 -19.68%
2003 -28.95%
2002 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$1.01K 27.48%
US
$340.35 2.89%
US
$257.52 61.43%
US
$187.22 0.00%
US
$1.92 -3.26%
AU